Indonesia vs Philippines: The number of people with susceptibility test result for rifampicin
Indonesia
144,511
in 2021
Philippines
111,868
in 2021
Indonesia rank
3rd
Philippines rank
6th
The number of people with susceptibility test result for rifampicin over time
- Indonesia
- Philippines
How they compare
Indonesia currently reports 144,511 against 111,868 in Philippines, a difference of 32,643.
That makes Indonesia's figure about 1.3 times Philippines's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Philippines ahead.
Indonesia ranks 3rd and Philippines ranks 6th of 155 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71,327 | 32,165 | 39,162 | Indonesia |
| 2020s | 121,178 | 97,208 | 23,971 | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Indonesia or Philippines?
- Indonesia, at 144,511 against 111,868 in Philippines as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Indonesia and Philippines?
- 32,643, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Philippines?
- 5 years are reported by both, from 2017 to 2021.
- How do Indonesia and Philippines rank globally for the number of people with susceptibility test result for rifampicin?
- Indonesia ranks 3rd and Philippines ranks 6th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.